Real-time enrollment status for this acute myeloid leukemia clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 9:50 AM UTC
| NCT Number | NCT06672146 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia |
| Phase | PHASE2 |
| Target Enrollment | 93 participants |
| Active Locations | 135 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | October 13, 2026 (3 days ago) |
As of October 16, 2026: Clinical trial NCT06672146 is currently recruiting participants. This phase2 study for acute myeloid leukemia is actively seeking new participants at 135 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06672146 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 135 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06672146 was last updated 3 days ago (October 13, 2026). HelloStudys verifies this status automatically.